<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K3L4M3" height="0" width="0" style="display:none;visibility:hidden">

Features Australia

Don’t axe QoVax

A priceless biobank with the answers to long Covid is threatened with destruction

18 March 2023

9:00 AM

18 March 2023

9:00 AM

Why has the Queensland health department withdrawn funding for its award-winning QoVax research program studying the safety and efficacy of Covid-19 vaccines?

Only last August, Queensland’s Health Minister, Yvette D’Ath, and the chief operating officer of Queensland Health, Dr David Rosengren, celebrated the work of the QoVax team, led by Professor Janet Davies, which was a highly commended finalist in the Pursuing Innovation category at the 2022 Queensland Health Awards for Excellence.

Already a subscriber? Log in

Black Friday sale

Subscribe today and get 10 weeks of The Spectator Australia for just $1

  • Unlimited access to spectator.com.au and app
  • The weekly edition on the Spectator Australia app
  • Spectator podcasts and newsletters
  • Full access to spectator.co.uk
Or

Unlock this article

REGISTER

You might disagree with half of it, but you’ll enjoy reading all of it. Try your first month for free, then just $2 a week for the remainder of your first year.


Comments

Black Friday sale

Subscribe today and get 10 weeks of The Spectator Australia for just $1

Already a subscriber? Log in

Close